Unia Europejska - grecki - EMA (European Medicines Agency)

leo pharma a/s - tralokinumab - Δερματίτιδα, Ατοπική - Άλλα δερματολογικά παρασκευάσματα - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.

Unia Europejska - grecki - EMA (European Medicines Agency)

ucb pharma s.a.   - bimekizumab - Ψωρίαση - Ανοσοκατασταλτικά - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.

Unia Europejska - grecki - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - spesolimab - Ψωρίαση - Ανοσοκατασταλτικά - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.

Unia Europejska - grecki - EMA (European Medicines Agency)

eli lilly nederland b.v. - mirikizumab - Κολίτιδα, ελκώδης - Ανοσοκατασταλτικά - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

Cypr - grecki - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

akis panayiotou & son ltd (0000003084) 4 yianos kranidiotis str, lefkosia, 1065, 22578 - cefprozil monohydrate - film coated tablets - 500mg - cefprozil monohydrate (8000003302) 523,1mg - cefprozil

Cypr - grecki - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

akis panayiotou & son ltd (0000003084) 4 yianos kranidiotis str, lefkosia, 1065, 22578 - cefprozil - film coated tablets - 250mg - cefprozil (8000001308) 250mg base - cefprozil

Cypr - grecki - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

akis panayiotou & son ltd (0000003084) 4 yianos kranidiotis str, lefkosia, 1065, 22578 - cefprozil monohydrate - powder for oral suspension - 250mg/5ml - cefprozil monohydrate (8000003302) 261,55mg - cefprozil

Grecja - grecki - Εθνικός Οργανισμός Φαρμάκων

novartis (hellas) a.e.b.e. - aldesleukin - ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ/ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ - 18 x10 6 iu/1ml(1mg/vial) - ineof00374 - aldesleukin - 18.000000 mu - aldesleukin

Grecja - grecki - Εθνικός Οργανισμός Φαρμάκων

meda pharmaceuticals s.a., greece Αγίου Δημητρίου 63, 17456 Αλιμος 210.6775690 - glucosamine sulfate - pd.ora.sol (ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ) - 1,884(1,5)g/sachet - glucosamine sulfate 1.500mg - glucosamine

Grecja - grecki - Εθνικός Οργανισμός Φαρμάκων

meda pharmaceuticals s.a., greece Αγίου Δημητρίου 63, 17456 Αλιμος 210.6775690 - glucosamine sulfate sodium salt - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 750mg/tab - glucosamine sulfate sodium salt 942mg - glucosamine